FINWIRES · TerminalLIVE
FINWIRES

B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating

By

Price: $17.44, Change: $+1.20, Percent Change: +7.42%

Related Articles